Center for Interventional Vascular Therapy, NewYork-Presbyterian Hospital, Columbia University Medical Center, 161 Fort Washington Ave., 6th Floor, New York, NY 10032, USA.
Curr Cardiol Rep. 2012 Oct;14(5):642-6. doi: 10.1007/s11886-012-0300-z.
Percutaneous coronary intervention (PCI) has seen steady technological progress over the past 3 decades. Despite improved patient safety and efficacy, modern interventionalists continue to face significant occupational hazards, including radiation exposure, cataracts, and orthopedic injuries. Robotic remote navigation systems have been developed to address risks and procedural challenges associated with conventional PCI. The first in-human experience using a modern robotic system for PCI yielded excellent results, with an overall technical success rate of 97.9 %. A larger multicenter prospective registry with this system is currently underway. Robotic PCI technology holds promise to reduce operator radiation exposure and musculoskeletal complaints. Postulated benefits to patients include more accurate lesion length calculations, precise stent placement, and reductions in radiation exposure and contrast-media delivery. The development of novel robotic remote control navigation systems represents the dawn of a new era of interventional cardiology.
经皮冠状动脉介入治疗（PCI）在过去 30 年中取得了稳定的技术进步。尽管患者的安全性和疗效得到了提高，但现代介入医生仍然面临着重大的职业危害，包括辐射暴露、白内障和骨科损伤。已经开发出机器人远程导航系统来解决与传统 PCI 相关的风险和程序挑战。首例使用现代机器人系统进行 PCI 的人体试验取得了优异的结果，总体技术成功率为 97.9%。目前正在进行一项更大的多中心前瞻性注册研究。机器人 PCI 技术有望减少操作人员的辐射暴露和肌肉骨骼投诉。推测对患者的益处包括更准确的病变长度计算、精确的支架放置以及减少辐射暴露和造影剂输送。新型机器人远程控制导航系统的开发代表着介入心脏病学新时代的曙光。
